Quick answer: Quadax and Waystar are both clearinghouse-class vendors. Quadax is known for iQ pre-submission edits and denial avoidance. Waystar is a larger payments platform with AltitudeAI, remits, and a broader module set. Pick Quadax if you want edit-heavy clearinghouse service. Pick Waystar if you want a platform plus AI on a national network.
Inclusion criteria: Head-to-head on deployment model, EHR fit, payer coverage, and whether you must replace a clearinghouse or BPO.
Honest limitations: Substrate does not replace a clearinghouse, EHR, coder, or patient-billing platform. It automates post-submission AR. Claim status includes denial root-cause analysis (eligibility, records, medical necessity, wrong route), not just a 277 code or an 835 variance. Clinical edge cases still go to staff. Coding, CDI, and patient-facing billing are out of scope.
At a glance
Where Quadax wins
- Pre-submission iQ edits aimed at stopping denials before the 837 leaves
- Buyers who want a clearinghouse specialist rather than a full Waystar platform
- Denial avoidance as the primary KPI, not agentic follow-up
Where Waystar wins
- KLAS-cited clearinghouse scale and 200+ EHR connections
- AltitudeAI, recoupment, and analytics in one platform
- Teams already on Waystar who should not dual-home 837s without a plan
Also consider Substrate
Also consider Substrate when the gap is post-submission follow-up on the current PM: live in days, EDI and portal coverage across 3,500+ payers, PM writeback with a video audit trail, and denial root-cause analysis as part of claim status (eligibility, records, medical necessity, or wrong route) rather than a 277 code or an 835 variance alone. Substrate does not replace a clearinghouse, EHR, coder, or patient-billing platform. Keep Quadax or Waystar for 837/835 and edits. Add an overlay when the claim is already out the door and the 277 is not the reason it is unpaid.
Research sources
Quadax iQ materials, Waystar clearinghouse and AltitudeAI pages, and 276/277 limitation guides. Confirm edit libraries and enrolled payers.